Enfusion Inc Share Price ENFN

Last updated on April 15, 2025 at 12:00 am IST

$₹

This instrument is not available for trading on the INDmoney app on 15 Apr 2025

Check the interactive Enfusion Inc Stock chart to analyse performance

Enfusion Inc Key Stats

Check Enfusion Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$0.0
Open	$10.75
Market Capitalization	$1.0B
Today's Volume	$2.5M
Revenue TTM	$201.6M
EBITDA	$12.7M
Earnings Per Share (EPS)	$0.03
PE Ratio	364.0
Profit Margin	1.4%
Quarterly Earnings Growth YOY	-0.82%
Return On Equity TTM	4.42%

Global Institutional Holdings in Enfusion Inc

Name
Holdings %
Name
Holdings %
ICONIQ Capital, LLC
14.81%
Brown Capital Management, LLC
7.54%
Hillhouse Capital Advisors, Ltd.
5.25%
Vanguard Group Inc
3.52%
BlackRock Inc
3.36%
Lead Edge Capital Management, LLC
2.54%

Analyst Recommendation on Enfusion Inc Stock

Rating

Trend

Sell

23%Buy

30%Hold

46%Sell

Based on 13 Wall street analysts offering stock ratings for Enfusion Inc(by analysts ranked 0 to 5 stars)

Enfusion Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$59.0M	-
Net Income	$12.7M	-
Net Profit Margin	21.44%	-

	FY20	Y/Y Change
Revenue	$79.6M	↑ 34.79%
Net Income	$4.1M	↓ 67.91%
Net Profit Margin	5.1%	↓ 16.34%

	FY21	Y/Y Change
Revenue	$111.7M	↑ 40.39%
Net Income	$-282.2M	↓ 7050.06%
Net Profit Margin	-252.68%	↓ 257.78%

	FY22	Y/Y Change
Revenue	$150.3M	↑ 34.6%
Net Income	$-13.3M	↓ 95.3%
Net Profit Margin	-8.82%	↑ 243.86%

	FY23	Y/Y Change
Revenue	$174.5M	↑ 16.09%
Net Income	$6.0M	↓ 145.43%
Net Profit Margin	3.45%	↑ 12.27%

	FY24	Y/Y Change
Revenue	$201.6M	↑ 15.51%
Net Income	$2.8M	↓ 53.15%
Net Profit Margin	1.4%	↓ 2.05%

Q3 FY23

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

	Q3 FY23	Q/Q Change
Revenue	$44.4M	↑ 3.83%
Net Income	$1.8M	↑ 190.62%
Net Profit Margin	4.12%	↑ 2.65%

	Q4 FY23	Q/Q Change
Revenue	$46.5M	↑ 4.8%
Net Income	$623.0K	↓ 65.92%
Net Profit Margin	1.34%	↓ 2.78%

	Q1 FY24	Q/Q Change
Revenue	$48.1M	↑ 3.37%
Net Income	$-539.0K	↓ 186.52%
Net Profit Margin	-1.12%	↓ 2.46%

	Q2 FY24	Q/Q Change
Revenue	$49.5M	↑ 2.92%
Net Income	$1.8M	↓ 438.78%
Net Profit Margin	3.69%	↑ 4.81%

	Q3 FY24	Q/Q Change
Revenue	$51.2M	↑ 3.46%
Net Income	$1.4M	↓ 22.51%
Net Profit Margin	2.77%	↓ 0.92%

	Q4 FY24	Q/Q Change
Revenue	$52.9M	↑ 3.46%
Net Income	$121.0K	↓ 91.45%
Net Profit Margin	0.23%	↓ 2.54%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$42.1M	-

	FY20	Y/Y Change
Profit	$58.2M	↑ 38.37%

	FY21	Y/Y Change
Profit	$79.9M	↑ 37.19%

	FY22	Y/Y Change
Profit	$103.2M	↑ 29.3%

	FY23	Y/Y Change
Profit	$116.9M	↑ 13.22%

	FY24	Y/Y Change
Profit	$136.7M	↑ 16.98%

Q3 FY23

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

	Q3 FY23	Q/Q Change
Profit	$29.9M	↑ 4.69%

	Q4 FY23	Q/Q Change
Profit	$30.9M	↑ 3.39%

	Q1 FY24	Q/Q Change
Profit	$31.9M	↑ 3.29%

	Q2 FY24	Q/Q Change
Profit	$33.5M	↑ 5.07%

	Q3 FY24	Q/Q Change
Profit	$34.8M	↑ 3.98%

	Q4 FY24	Q/Q Change
Profit	$36.5M	↑ 4.92%

FY19

FY20

FY21

FY22

	FY19	Y/Y Change
Operating Cash Flow	$12.3M	-
Investing Cash Flow	$-4.4M	-
Financing Cash Flow	$-7.5M	-

	FY20	Y/Y Change
Operating Cash Flow	$1.7M	↓ 86.47%
Investing Cash Flow	$-5.1M	↑ 14.43%
Financing Cash Flow	$11.6M	↓ 253.28%

	FY21	Y/Y Change
Operating Cash Flow	$-318.0K	↓ 119.1%
Investing Cash Flow	$-8.0M	↑ 58.13%
Financing Cash Flow	$58.8M	↑ 409.12%

	FY22	Y/Y Change
Operating Cash Flow	$14.2M	↓ 4551.57%
Investing Cash Flow	$-7.9M	↓ 1.04%
Financing Cash Flow	$-8.0M	↓ 113.52%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$12.1M	↑ 101.16%
Investing Cash Flow	$-2.6M	↑ 17.49%
Financing Cash Flow	$-5.3M	↓ 82.79%

About Enfusion Inc

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also provides Accounting/General Ledger System, a proper double-entry ledger that automates the posting of general ledger journal entries for all cash and securities transactions for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

Organization	Enfusion Inc
Employees	1143
CEO	Mr. Oleg Movchan
Industry	Miscellaneous

Key Management of Enfusion Inc

Name	Title
Mr. Oleg Movchan	CEO & Director
Mr. Bradley Herring	Chief Financial Officer
Mr. Neal Pawar	Chief Operating Officer
Mr. Stephen Malherbe	Managing Partner
Ms. Valeria Gutowski	Chief Accounting Officer
Mr. Daniel Groman	Chief Technology Officer
Mr. Matthew R. Campobasso	General Counsel & Corporate Secretary
Ms. Bronwen Bastone	Chief People Officer
Mr. Joseph Defeo	Global Head of Managed Services Production
Mr. Jeff Young	Head of Implementation

Important FAQs about investing in ENFN Stock from India :

What is Enfusion Inc share price today?

Enfusion Inc share price today is as on April 15, 2025 at 12:00 am IST at the close of the market. Enfusion Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Enfusion Inc share?

Enfusion Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Enfusion Inc stock price today i.e. April 15, 2025 at 12:00 am IST is closed at , lower by 100% versus the 52 week high.

How to invest in Enfusion Inc Stock (ENFN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Enfusion Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Enfusion Inc Shares .

What is the minimum amount required to buy Enfusion Inc Stock (ENFN) from India?

Indian investors can start investing in Enfusion Inc (ENFN) shares with as little as ₹96.3775 or $1 (as of May 22, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹963.77 in Enfusion Inc stock (as per the Rupee-Dollar exchange rate as on May 22, 2026). Learn more about fractional shares .

What are the returns that Enfusion Inc has given to Indian investors in the last 5 years?

Enfusion Inc stock has given 0.0% share price returns and 32.33% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?

Discover More

Sangamo Therapeutics, Inc.
$0.16
+0.0%
Chain Bridge I
$11.90
-6.89%
Franklin Solana ETF
$15.25
+2.01%
21shares Sui ETF Common Shares of Beneficial Interest Shares
$22.89
+6.56%
2x Stellar ETF
$14.39
+1.41%
Listed Funds Trust 21Shares 2x Long Dogecoin ETF
$7.43
+2.34%
Teucrium 2x Long Daily XRP ETF
$3.85
+1.32%
WisdomTree Trust WisdomTree Inflation Plus Fund
$39.08
-0.53%
VanEck Avalanche ETF Common Shares of Beneficial Interest
$19.81
+2.01%

Explore all